🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, open-label study to assess the PK of single 100 mg ...
Status
Completed
Location
DaVita Clinical Research
Start Date
2017-09-21
Trial ID
NCT03290443
Treatments Being Tested
This phase II trial studies the side effects of using enasidenib as mainten...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2019-12-23
Trial ID
NCT03728335
Treatments Being Tested
This phase II trial studies how well enasidenib and azacitidine work in tre...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-09-18
Trial ID
NCT03683433
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of a enas...
Status
Completed
Location
City of Hope Medical Center
Start Date
2023-04-28
Trial ID
NCT05441514
Treatments Being Tested
This phase II trial studies the side effects of enasidenib and sees how wel...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2023-08-14
Trial ID
NCT04203316
Treatments Being Tested
AG-221 is a first-in-class drug targeted specifically to inhibit the IDH2 e...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02218346
Treatments Being Tested
This trial evaluates how well CPX-351 and enasidenib work in treating patie...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2019-04-12
Trial ID
NCT03825796
Treatments Being Tested
This phase Ib trial evaluates the best dose and effect of glasdegib in comb...
Status
Withdrawn
Location
City of Hope Meidcal Center
Start Date
2022-06-25
Trial ID
NCT04655391
This is a multi-center, open-label study to assess the PK of single 100 mg ...
Status
Completed
Location
Local Institution - 002
Start Date
2020-11-13
Trial ID
NCT04573582
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested